Beyond its potential use as a prognostic marker, our findings implicating SPINK1 as a functional driver of ovarian cancer cell growth and survival suggest that it may offer a target for pharmacological intervention in the subset of patients with SPINK1-expressing tumors. The gene discussed is SPINK1; the disease is ovarian cancer.